Filter your results
- 2
- 2
- 2
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.Malaria Journal, 2012, 11, pp.45. ⟨10.1186/1475-2875-11-45⟩
Journal articles
pasteur-00836167v1
|
||
|
PCR correction strategies for malaria drug trials: updates and clarificationsThe Lancet Infectious Diseases, 2020, 20 (1), pp.e20-e25. ⟨10.1016/s1473-3099(19)30426-8⟩
Journal articles
hal-03059787v1
|